Vitiligo: Pathogenesis, clinical variants and treatment approaches

Giannicola Iannella, Antonio Greco, Dario Didona, Biagio Didona, Guido Granata, Alessandra Manno, Benedetta Pasquariello, Giuseppe Magliulo

Research output: Contribution to journalArticle

Abstract

Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown, which usually occurs with asymptomatic whitish patch or macule. Although several hypotheses have been proposed in the literature, the leading theory is still the auto-immune etiology linked to specific genetic mutations. Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi. Sensorineural hearing loss was reported in several vitiligo patients due to a reduction in the number of melanocytes contained in the membranous labyrinth of the inner ear. Because of its complexity, several therapeutic options are available to treat this systemic disease.

Original languageEnglish
Pages (from-to)335-343
Number of pages9
JournalAutoimmunity Reviews
Volume15
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Keywords

  • Autoimmune diseases
  • Hearing loss
  • NB-UVB
  • Oxidative stress
  • Prednisolone
  • Vitiligo

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Vitiligo: Pathogenesis, clinical variants and treatment approaches'. Together they form a unique fingerprint.

  • Cite this

    Iannella, G., Greco, A., Didona, D., Didona, B., Granata, G., Manno, A., Pasquariello, B., & Magliulo, G. (2016). Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviews, 15(4), 335-343. https://doi.org/10.1016/j.autrev.2015.12.006